Correlation between 25-hydroxyvitamin D and nephroblastoma in children and its value in assessing disease prognosis.
10.7499/j.issn.1008-8830.2212089
- Author:
Li ZHAO
1
;
Xu-Kai MA
1
;
Yu LIU
1
;
Ying-Bin YUE
1
;
Mei YAN
1
Author Information
1. Department of Pediatrics, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830000, China.
- Publication Type:Journal Article
- Keywords:
25-Hydroxyvitamin D;
Child;
Nephroblastoma;
Prognostic value
- MeSH:
Humans;
Child;
Creatinine;
Vitamin D Deficiency/complications*;
Vitamin D;
Calcifediol;
Prognosis;
Wilms Tumor;
Kidney Neoplasms/complications*
- From:
Chinese Journal of Contemporary Pediatrics
2023;25(5):483-488
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:To study the correlation between 25-hydroxyvitamin D [25-(OH)D] and nephroblastoma in children and its value in assessing the prognosis of the disease.
METHODS:A total of 50 children with nephroblastoma who were admitted from January 2018 to December 2022 were included as the nephroblastoma group, and according to the postoperative pathological type, they were divided into a good prognosis group with 38 children and a poor prognosis group with 12 children. A total of 50 healthy children who underwent physical examination during the same period of time served as the healthy control group. The above groups were compared in terms of serum creatinine and 25-(OH)D level. A Spearman correlation analysis was used to investigate the correlation between serum 25-(OH)D level and therapeutic effect reaction. A multivariate logistic regression analysis was used to identify the risk factors affecting the prognosis of nephroblastoma in children.
RESULTS:The nephroblastoma group had significantly lower levels of serum creatinine and 25-(OH)D than the healthy control group (P<0.05). Compared with the good prognosis group, the poor prognosis group had a significantly larger tumor diameter, a significantly higher proportion of children with stage III-IV tumors, a significantly higher rate of tumor metastasis, and significantly lower serum levels of creatinine and 25-(OH)D (P<0.05). The Spearman correlation analysis showed that serum 25-(OH)D level was negatively correlated with therapeutic effect reaction (rs=-0.685, P<0.001). The multivariate logistic regression analysis showed that tumor diameter ≥10 cm, stage III-IV tumors, presence of tumor metastasis, and 25-(OH)D <19 ng/mL were closely associated with the poor prognosis of nephroblastoma in children (P<0.05). Serum 25-(OH)D level had an area under the curve of 0.805 (95%CI: 0.706-0.903, P<0.001) in evaluating the prognosis of nephroblastoma in children, with a Youden index of 0.512, a sensitivity of 0.938, and a specificity of 0.575 at the optimal cut-off value of 1.764 ng/mL.
CONCLUSIONS:There is a significant correlation between 25-(OH)D level and the prognosis of nephroblastoma in children, and 25-(OH)D can be used for prognosis prediction.
